Literature DB >> 29218932

[Research progress of Bixie].

Chong Chen1, Chen-Hong Zeng1, Si-Qi Zhang1, Li Wei1.   

Abstract

The Dioscorea hypoglauca rhizome and D. spongiosa rhizome in "China Pharmacopoeia" are often used as Bixie in clinically, with the function of removing dampness, clearing away turbidness and dispelling wind to remove pain, and has been widely used in stranguria marked by chyluria, joint stiffness and rheumatic arthralgia. It has obvious curative effect and broad application prospect. However, in recent years the progress of research is slow for its miscellaneous sources, chaotic varieties and lack of relevant quality assessment. The previous research on Bixie is mainly reflected in the chemical compositions, mainly including steroids, diarylheptanoids and lignans and so on. Among them, steroidal saponins are the main components and the main effective substances for their pharmacological activities. Recent studies have shown that Bixie and its main components have significant effects in anti-trioxypurine, anti-inflammation, analgesia and anti-osteoporosis, and have made great progress, providing an experimental basis for the research and development of clinical drugs. But the specific substance and specific mechanism of its pharmacological action are not clear, and need further exploration. By consulting the relevant literature at home and abroad, the author has summarized the chemical constituents, quality evaluation, pharmacological action of Bixie, hoping to provide a reference for further research, development and utilization of Bixie. Copyright© by the Chinese Pharmaceutical Association.

Entities:  

Keywords:  Bixie ; chemical constituents ; pharmacological action ; quality evaluation

Mesh:

Substances:

Year:  2017        PMID: 29218932     DOI: 10.19540/j.cnki.cjcmm.20170731.005

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  2 in total

1.  Total Saponin of Dioscorea collettii Attenuates MSU Crystal-Induced Inflammation by Inhibiting the Activation of the TLR4/NF-κB Signaling Pathway.

Authors:  Li Guoying; Li Li; Yang Siyue; Lv Lei; Chen Guangliang
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-20       Impact factor: 2.629

2.  Preventive effect of dioscin against monosodium urate-mediated gouty arthritis through inhibiting inflammasome NLRP3 and TLR4/NF-κB signaling pathway activation: an in vivo and in vitro study.

Authors:  Jieru Han; Guangyu Shi; Wenhao Li; Ying Xie; Fuzhen Li; Deyou Jiang
Journal:  J Nat Med       Date:  2020-08-06       Impact factor: 2.343

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.